CTLA4 Haploinsufficency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which CTLA4 Haploinsufficency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 1/2

NCT03733067

Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsuffi…

Background: CTLA4 stands for cytotoxic T-lymphocyte antigen-4. It is a protein the body makes naturally to check its immune system from attacking itself. Some…

United States0Started 2023-11-30

Treatment: abatacept, Placebo